KENGREAL Trademark

Trademark Overview

On Tuesday, May 9, 2017, a trademark application was filed for KENGREAL with the United States Patent and Trademark Office. The USPTO has given the KENGREAL trademark a serial number of 87442665. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 14, 2020. This trademark is owned by Chiesi Farmaceutici S.P.A.. The KENGREAL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, a platelet inhibiting drug administered intravenously
kengreal

General Information

Serial Number87442665
Word MarkKENGREAL
Filing DateTuesday, May 9, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 14, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 12, 2017

Trademark Statements

Indication of Colors claimedThe color(s) black, yellow, purple and green is/are claimed as a feature of the mark.
Description of MarkThe mark consists of the word "KENGREAL" in black letters in a stylized font; an arc appears atop the word "KENGREAL" in yellow, purple and green; a triangle shape appears in front of the arc in the color purple.
Goods and ServicesPharmaceutical preparations, namely, a platelet inhibiting drug administered intravenously

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, May 13, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameChiesi Farmaceutici S.P.A.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressParma 43122
IT
Party NameChiesi Farmaceutici S.P.A.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressParma 43122
IT

Trademark Events

Event DateEvent Description
Monday, December 14, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 14, 2020ABANDONMENT - NO USE STATEMENT FILED
Tuesday, April 28, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, April 25, 2020EXTENSION 5 GRANTED
Friday, April 17, 2020EXTENSION 5 FILED
Saturday, April 25, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, April 17, 2020TEAS EXTENSION RECEIVED
Thursday, October 24, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 22, 2019EXTENSION 4 GRANTED
Tuesday, October 22, 2019EXTENSION 4 FILED
Tuesday, October 22, 2019TEAS EXTENSION RECEIVED
Thursday, May 2, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 30, 2019EXTENSION 3 GRANTED
Tuesday, April 30, 2019EXTENSION 3 FILED
Tuesday, April 30, 2019TEAS EXTENSION RECEIVED
Friday, October 26, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 24, 2018EXTENSION 2 GRANTED
Wednesday, October 24, 2018EXTENSION 2 FILED
Wednesday, October 24, 2018TEAS EXTENSION RECEIVED
Tuesday, May 1, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 27, 2018EXTENSION 1 GRANTED
Friday, April 27, 2018EXTENSION 1 FILED
Friday, April 27, 2018TEAS EXTENSION RECEIVED
Tuesday, November 7, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 12, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 12, 2017PUBLISHED FOR OPPOSITION
Wednesday, August 23, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 9, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, August 7, 2017ASSIGNED TO EXAMINER
Tuesday, May 16, 2017NOTICE OF DESIGN SEARCH CODE E-MAILED
Saturday, May 13, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, May 12, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

kengreal drug administered intravenously inhibiting platelet preparations namely pharmaceutical